Using patient-reported measures to predict hospitalisation in a population-based lupus cohort
This study suggests that patient-reported SLE symptoms and disease activity, specifically certain components of the SLAQ, may be of value in SLE risk management when considering hospitalisation reduction as a treatment goal.
Authors
- Sandra Sze-jung Wu
- Sung Sam Lim (ORCID: https://orcid.org/0000-0003-2361-0787)
- Ryan D. Ross (ORCID: https://orcid.org/0000-0003-3760-234X)
- Gary Bryant (ORCID: https://orcid.org/0000-0001-5483-7592)
- Gaobin Bao
- Megan Richards (ORCID: https://orcid.org/0000-0003-0737-389X)
- Liisa Palmer
Institutions
- Emory University (US)
- Merit Network (US)
- AstraZeneca (United States) (US)
Publication Details
- Journal
- Lupus Science & Medicine
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1136/lupus-2024-001406
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- AstraZeneca